Completed PHASE4 INTERVENTIONAL 2-arm NCT01536470

Intraoperative Noradrenaline to Control Arterial Pressure (INPRESS Study) (INPRESS)

Effectiveness of Noradrenaline to Control Intraoperative Arterial Pressure in High-risk Surgical Patients: A Multicentre Prospective Randomized Controlled Trial

Sponsor: Aguettant laboratory

Conditions Control of Arterial Blood Pressure

Interventions Ephedryne chorydrate noradrenaline

Updated 5 times since 2017 Last updated: Sep 30, 2016 Started: Mar 31, 2012 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01536470, this PHASE4 trial focuses on Control of Arterial Blood Pressure and remains completed. Sponsored by Aguettant laboratory, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aguettant laboratory
University Hospital, Clermont-Ferrand

Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clermont-Ferrand, France